Register to chat with like-minded investors on our interactive forums.
Period:
Draw Mode:
| Volume | 0 |
|
|||||
| News | - | ||||||
| Day High | Low High |
||||||
| Day Low | |||||||
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Sol Gel Technologies Ltd | SLGL | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded
|
|
|---|---|---|---|---|
| 0.00 | 0.00% | 0.92 | 04:17:27 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 0.92 |
| Trades | Volume | Avg Volume | 52 Week Range |
|---|---|---|---|
| 0 | 0 | - | 0.79 - 4.0498 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| - | 0 | $ 0.92 | USD |
Sol Gel Technologies Ltd Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 25.63M | 27.86M | - | 1.61M | -27.24M | -0.98 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
Sol Gel Technologies News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical SLGL Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 0.871 | 1.00 | 0.8569 | 0.9288346 | 9,703 | 0.049 | 5.63% |
| 1 Month | 0.98 | 1.07 | 0.79 | 0.9488246 | 31,414 | -0.06 | -6.12% |
| 3 Months | 1.49 | 1.5754 | 0.79 | 1.06 | 30,033 | -0.57 | -38.26% |
| 6 Months | 1.41 | 1.59 | 0.79 | 1.12 | 24,785 | -0.49 | -34.75% |
| 1 Year | 3.60 | 4.0498 | 0.79 | 1.79 | 19,196 | -2.68 | -74.44% |
| 3 Years | 14.39 | 14.80 | 0.79 | 6.11 | 18,630 | -13.47 | -93.61% |
| 5 Years | 6.99 | 26.52 | 0.79 | 9.27 | 27,236 | -6.07 | -86.84% |
Sol Gel Technologies Description
| Sol-Gel Technologies Ltd is a clinical-stage specialty pharmaceutical company. It is engaged in identifying, developing and commercializing branded and generic topical drug products for the treatment of skin diseases. The company's product candidate pipeline consists of silica-based microencapsulation technology platform, and several generic product candidates across multiple indications. |
